BMRN - Biomarin Pharmaceutical Inc.

Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Alexander Hardy	214.6K	$11.95M	-
CFO	Brian Mueller	123.3K	$6.86M	-
VP	Charles Greg Guyer	84.1K	$4.68M	-
VP	George Eric Davis	61.0K	$3.40M	-
Dir	Robert J. Hombach	49.4K	$2.75M	-

Buys and sells only

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%
May 8, 2020	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	20,000	$91.72	$1,834,400.00	-6.3%
May 4, 2020	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	9,000	$88.61	$797,520.00	-2.9%
May 1, 2020	George Eric Davis65	EVP, General Counsel	Sell	12,504	$89.38	$1,117,607.52	-16.0%
Apr 28, 2020	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	40,000	$97.66	$3,906,200.00	-11.8%
Apr 24, 2020	Henry J Fuchs	President, Worldwide R& D	Sell	20,000	$95.88	$1,917,617.48	-16.3%
Apr 20, 2020	Henry J Fuchs	President, Worldwide R& D	Sell	17,213	$90.00	$1,549,170.00	-12.3%
Apr 9, 2020	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	10,000	$79.06	$790,600.00	-3.2%
Apr 8, 2020	Jeffrey Robert Ajer58	EVP, Chief Commercial Officer	Sell	2,407	$79.98	$192,511.86	-3.7%
Apr 1, 2020	Jeffrey Robert Ajer58	EVP, Chief Commercial Officer	Sell	1,537	$82.00	$126,034.00	-2.3%
Mar 25, 2020	Jeffrey Robert Ajer58	EVP, Chief Commercial Officer	Sell	3,659	$76.18	$278,733.22	-5.2%